الرجوع إلى التحديثات

Tuberculosis - October 2022 update

Select language:

The following chapters, appendices and drug information sheets have been updated or added:

Chapters
  • Chapter 3: Diagnosis and follow-up investigations
  • Chapter 8: Tuberculosis drugs and treatment regimens
  • Chapter 9: Treatment of drug-susceptible tuberculosis
  • Chapter 15: Follow-up of staff exposed to tuberculosis
Appendices
  • Appendix 1. Xpert assays
  • Appendix 2. Interpretation of Xpert assay results
  • Appendix 5. Time required for diagnostic test results
  • Appendix 11. Use of tuberculosis drugs in pregnant or breastfeeding women
  • Appendix 13. Daily dose of tuberculosis drugs using fixed-dose combinations
  • Appendix 14. Monitoring of patients on drug-susceptible tuberculosis treatment
  • Appendix 15. Monitoring of patients on drug-resistant tuberculosis treatment
  • Appendix 16. Additional investigations in drug-resistant TB
  • Appendix 19. Drug interactions and overlapping toxicities
Drug information sheets
  • Bedaquiline
  • Delamanid
  • Levofloxacin
  • Linezolid
  • Moxifloxacin
  • Para-aminosalicylate sodium
  • Pretomanid
  • Rifapentine